<VariationArchive VariationID="7257" VariationName="NM_005251.3(FOXC2):c.914_921del (p.Tyr305fs)" VariationType="Deletion" Accession="VCV000007257" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-17" DateCreated="2019-01-05" MostRecentSubmission="2024-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22296" VariationID="7257">
      <GeneList>
        <Gene Symbol="FOXC2" FullName="forkhead box C2" GeneID="2303" HGNC_ID="HGNC:3801" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86566829" stop="86569728" display_start="86566829" display_stop="86569728" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86600856" stop="86602538" display_start="86600856" display_stop="86602538" Strand="+" />
          </Location>
          <OMIM>602402</OMIM>
          <Haploinsufficiency last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005251.3(FOXC2):c.914_921del (p.Tyr305fs)</Name>
      <CanonicalSPDI>NC_000016.10:86568248:ACGCCGCC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86568249" stop="86568256" display_start="86568249" display_stop="86568256" variantLength="8" positionVCF="86568248" referenceAlleleVCF="TACGCCGCC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86601855" stop="86601862" display_start="86601855" display_stop="86601862" variantLength="8" positionVCF="86601854" referenceAlleleVCF="TACGCCGCC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y305fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012025.2" sequenceAccession="NG_012025" sequenceVersion="2" change="g.6421_6428del">
            <Expression>NG_012025.2:g.6421_6428del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005251.3" sequenceAccession="NM_005251" sequenceVersion="3" change="c.914_921del" MANESelect="true">
            <Expression>NM_005251.3:c.914_921del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005242.1" sequenceAccession="NP_005242" sequenceVersion="1" change="p.Tyr305fs">
            <Expression>NP_005242.1:p.Tyr305fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292" sequenceAccession="LRG_1292">
            <Expression>LRG_1292:g.6421_6428del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292t1" sequenceAccession="LRG_1292t1">
            <Expression>LRG_1292t1:c.914_921del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1292p1" sequenceAccession="LRG_1292p1" change="p.Tyr305fs">
            <Expression>LRG_1292p1:p.Tyr305fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.86568249_86568256del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.86568249_86568256del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.86601855_86601862del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.86601855_86601862del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="602402.0009" DB="OMIM" />
        <XRef Type="rs" ID="1567571564" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005251.3(FOXC2):c.914_921del (p.Tyr305fs) AND Distichiasis-lymphedema syndrome" Accession="RCV000007679" Version="7">
        <ClassifiedConditionList TraitSetID="1971">
          <ClassifiedCondition DB="MedGen" ID="C0265345">Distichiasis-lymphedema syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-01-05" MostRecentSubmission="2024-02-04">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11499682</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12114478</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12485195</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1971" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2577" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Distichiasis-lymphedema syndrome</ElementValue>
                <XRef ID="Lymphedema+distichiasis+syndrome/4357" DB="Genetic Alliance" />
                <XRef ID="8634009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lymphedema with distichiasis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary lymphedema-distichiasis syndrome (subtype)</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Lymphedema-distichiasis syndrome (referred to as LDS in this GeneReview) is characterized by lower-limb lymphedema, and distichiasis (aberrant eyelashes ranging from a full set of extra eyelashes to a single hair). Lymphedema typically appears in late childhood or puberty, is confined to the lower limbs with or without involvement of the external genitalia, and is often asymmetric; severity varies within families. Males develop edema at an earlier age and have more problems with cellulitis than females. Distichiasis, which may be present at birth, is observed in 94% of affected individuals. About 75% of affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia; other common findings include varicose veins and ptosis.</Attribute>
                <XRef ID="NBK1457" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="333" />
                <XRef ID="333" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301630</ID>
                <ID Source="BookShelf">NBK1457</ID>
              </Citation>
              <XRef ID="33001" DB="Orphanet" />
              <XRef ID="C0265345" DB="MedGen" />
              <XRef ID="MONDO:0007922" DB="MONDO" />
              <XRef Type="MIM" ID="153400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27880" SubmissionDate="2019-01-02" DateLastUpdated="2019-01-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602402.0009_LYMPHEDEMA-DISTICHIASIS SYNDROME" title="FOXC2, 8-BP DEL, NT914_LYMPHEDEMA-DISTICHIASIS SYNDROME" />
        <ClinVarAccession Accession="SCV000027880" DateUpdated="2019-01-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2002-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Bahuau et al. (2002) reported a family showing autosomal dominant segregation of upper- and lower-eyelid distichiasis in 7 relatives over 3 generations, in addition to below-knee lymphedema of pubertal onset in 3 (LPHDST; 153400). Two children had cleft palate in addition to distichiasis, but without the previously reported association of Pierre Robin sequence (Bell et al., 2001; Brice et al., 2002). Other ophthalmologic anomalies included divergent strabismus and early-onset myopia. Although no family member had pterygium colli, congenital heart disease, or facial dysmorphism, the disorder was linked to markers on chromosome 16q24.3 and was thus proposed to be allelic to lymphedema-distichiasis syndrome. Bahuau et al. (2002) demonstrated an out-of-frame deletion of the FOXC2 gene, 914-921del, segregating with the syndrome. Whether the heterogeneity observed was related to genotype-phenotype correlation, a hypothesis not primarily supported by the apparent loss-of-function mechanism of the mutations, or governed by modifying genes, was undetermined.</Attribute>
              <Citation>
                <ID Source="PubMed">12485195</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">11499682</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">12114478</ID>
              </Citation>
              <XRef DB="OMIM" ID="153400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC2" />
          </GeneList>
          <Name>FOXC2, 8-BP DEL, NT914</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">8-BP DEL, NT914</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602402.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LYMPHEDEMA-DISTICHIASIS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7130655" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="a9179c1cf4efbf81b596da20ae94ee540d9e68cd5049c8f05f9f6a3c4f32d28e|OMIM:153400" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003822092" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005251.2:c.914_921del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="153400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7130655" TraitType="Disease" MappingType="XRef" MappingValue="153400" MappingRef="OMIM">
        <MedGen CUI="C0265345" Name="Distichiasis-lymphedema syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="27880" TraitType="Disease" MappingType="Name" MappingValue="LYMPHEDEMA-DISTICHIASIS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265345" Name="Distichiasis-lymphedema syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

